A recent Cleveland Clinic study used AI to create digital twins of patients' metabolisms—and cured 7 in 10 type 2 diabetics.

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

Researchers have developed a new tool, FibrilPaint combined with the FibrilRuler test, that allows scientists to directly ...

Research shows the p-tau217 blood test can indicate very high risk of Alzheimer's disease before symptoms begin, offering ...

There are nearly 7 million people in the U.S. that suffer from Alzheimer's, and that number is expected to double by 2060 ...

A large study found that people with impaired kidneys tend to have higher Alzheimer’s biomarkers, yet they don’t face a ...

The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...

There is no single, easy test to diagnose Alzheimer’s, but a new review of 18 scientific studies confirms that a simple blood ...

People with impaired kidney function have higher levels of Alzheimer's biomarkers in their blood, but not an increased risk ...

Washington University School of Medicine researchers presented a study linking obesity to an increase in the progression ...

The prospect of diagnosing cancer through painless methods—such as a simple AI-assisted blood or urine test that detects tiny ...